Entereg-d5 基本信息
| 中文名称 | Entereg-d5 |
|---|---|
| 中文同义词 | [2H5]-ALVIMOPAN(R&D);爱维莫潘-D5 |
| 英文名称 | Entereg-d5 |
| 英文同义词 | Avimopan Carboxylic acid metabolite D5;Alvimopan-d5 (R&D);ADL 8-2698-d5;AlviMopan-d5;Entereg-d5;LY 246736-d5;rac-N-[2-[[4-(3-Hydroxyphenyl)-3,4-diMethyl-1-piperidinyl]Methyl]-1-oxo-3-(phenyl-d5)propyl]glycine;[2H5]-Alvimopan (R& |
| CAS号 | 1217616-62-0 |
| 分子式 | C25H32N2O4 |
| 分子量 | 424.53258 |
| EINECS号 | |
| 相关类别 | Aromatics, Chiral Reagents, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals |
| Mol文件 | 1217616-62-0.mol |
| 结构式 |  |
Entereg-d5 性质
用途
Alvimopan-d5 is the deuterium labeled Alvimopan. Alvimopan (ADL 8-2698) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM.